MedPath

浙江麒正药业有限公司

Ownership
-
Established
2019-10-17
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Sitafloxacin Tablets

Product Name
西他沙星片
Approval Number
国药准字H20249655
Approval Date
Dec 1, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.